Health tech firm forecasts expansion after shift to remote patient care
Saltaire-based Advanced Digital Innovation (UK) (ADI), is forecasting record growth for its MyPathway health platform this year after securing six major contract wins in the last few months.
The business is seeking new investment to fund this opportunity, and is anticipating sales growth of more than 130%.
It explains this has been made possible by NHS Trusts driving a rapid shift to online care for patients, who have been prevented from visiting hospitals due to the pandemic.
ADI offers the MyPathway software platform for remote specialist healthcare.
It has won new contracts with NHS Leeds CCG, NHS Sheffield CCG, Sheffield Institute for Translational Neuroscience/University of Sheffield, North West Boroughs Healthcare NHS Foundation Trust and Trinity College Dublin for Ireland’s Health Service Executive, adding to its existing customer relationships.
33,000 new patients have also signed up to MyPathway in recent months, taking total patient users to nearly 60,000.
John Eaglesham, ADI chief executive, said: “After a record year, our business is now seeing its biggest ever growth opportunity.
“COVID-19 has created, almost overnight, a transformational change in the NHS towards embracing new ways of communicating and caring for patients.
“Whilst this has been accelerated by the pandemic, it heralds a long term and long overdue shift in how the NHS interacts with patients, catching up to the online communications used in other sectors.
“Where making fundamental changes in the NHS might have been a challenge six months ago, we are now pushing on open doors as the NHS looks for new ways to provide care and manage the backlog of patients whose appointments were cancelled due to the outbreak.
“We are embarking on this second funding round in order to address this substantial opportunity and continue to pioneer new ways of caring for vulnerable patients by increasing both the number of customers we work with and the number of clinical pathways we address.”
ADI was formed in 2012 by serial Yorkshire entrepreneur, Bob Gomersall, to solve innovation challenges within the NHS and the defence industry.
Now entirely focused on providing telehealth solutions for patients’ complex care needs, the business works with NHS Trusts around the UK and overseas.
In August 2019, ADI secured £650,000 funding from Mercia Equity Finance, part of the Northern Powerhouse Investment Fund, to boost uptake of MyPathway, and is now looking to fund its next growth phase.
MyPathway, removes the need for appointment calls and letters, and enables patients to access online advice on how to manage their condition, attend virtual appointments with their consultant and book face-to-face appointments where they are needed.
It reduces the need for hospital visits by as much as 80%. The technology is now being used to provide care and physiotherapy for conditions including motor neurone disease, musculoskeletal problems and chronic pain.